SLC5A2 and heart failure: A recent multinational observational study demonstrated that the time after a recent heart failure hospitalization to initiate a GDMT was longer for newer GDMT (ARNIs and SGLT2 inhibitors), highlighting that sequential strategy may often lead to clinical inertia [89].